EBIT: Income before interest and taxes.
Cassava Sciences, Inc. (SAVA) had EBIT of $-45.39M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-44.22M |
|
-- |
|
-- |
|
$45.39M |
|
$-45.39M |
|
$1.17M |
|
$-44.22M |
|
$-44.22M |
|
$-44.22M |
|
$-44.22M |
|
$-44.22M |
|
$-44.22M |
|
|
EBIT |
$-45.39M |
$-45.17M |
|
48.31M |
|
48.31M |
|
$-0.92 |
|
$-0.92 |
|
| Balance Sheet Financials | |
$114.82M |
|
$20.56M |
|
$20.56M |
|
$135.38M |
|
$47.33M |
|
-- |
|
$0.08M |
|
$47.41M |
|
$87.97M |
|
$87.97M |
|
$87.97M |
|
48.31M |
|
| Cash Flow Statement Financials | |
$-16.28M |
|
-- |
|
$0.09M |
|
$128.57M |
|
$112.38M |
|
$-16.19M |
|
$9.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.43 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.28M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-50.27% |
|
-50.27% |
|
-32.67% |
|
-50.27% |
|
$1.82 |
|
$-0.34 |
|
$-0.34 |
|